180 Life Sciences Corp. Announces Closing of $6.5 Million Registered Direct Offering
Yahoo! Finance
PALO ALTO, Calif., July 21, 2022 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF, “180 Life Sciences” or the “Company”), a clinical-stage biotechnology company, today announced the closing of its previously-announced registered direct offering to a single healthcare-focused U.S. institutional investor of 6,132,076 shares of the Company’s common stock (including common stock equivalents in lieu thereof) and warrants to purchase up to 6,132,076 shares of common stock at a purchase price
Continue Reading